YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
about
NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesInfluenza Virus Induces Cholesterol-Enriched Endocytic Recycling Compartments for Budozone Formation via Cell Cycle-Independent Centrosome MaturationFormation of amyloid-like fibrils by Y-box binding protein 1 (YB-1) is mediated by its cold shock domain and modulated by disordered terminal domainsCentrosome maturation requires YB-1 to regulate dynamic instability of microtubules for nucleus reassemblyIntegrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate.YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancerPrognostic role of YB-1 expression in breast cancer: a meta-analysisA clinical overview of centrosome amplification in human cancers.YB-1 drives preneoplastic progression: Insight into opportunities for cancer preventionThe Many Virtues of tRNA-derived Stress-induced RNAs (tiRNAs): Discovering Novel Mechanisms of Stress Response and Effect on Human HealthYB-1: oncoprotein, prognostic marker and therapeutic target?Triple-negative breast cancer: investigating potential molecular therapeutic target.Deregulation of splicing factors and breast cancer development.Centrosome amplification: a suspect in breast cancer and racial disparities.Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseInhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerTargeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance.Y-box protein-associated acidic protein (YBAP1/C1QBP) affects the localization and cytoplasmic functions of YB-1.Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer
P2860
Q24298410-717ABA9B-F9E5-425B-9F94-A64FC25FFB04Q27316852-87CAB262-2722-489A-8A3A-70438F467537Q30155314-C3843BB8-1201-48BB-B4F1-8A7B8D020360Q30624768-45A2AA98-1C3A-4AC6-8E39-223344F2BB9CQ34484279-D807E301-DC0D-4466-B3F5-97A947E1F95EQ35063920-746847B8-0084-4BF0-9478-291DA8B3BB99Q35479413-2C73CCA6-2E3E-4D9A-BC8A-AD5E1F408E0BQ35479894-BEC09483-ABA6-4060-AC39-90D43A24DF83Q35640233-779290A1-10A3-42BC-A1CE-84146004BBFCQ36444185-33742694-AAFD-408C-87FB-355F6B6D5F9CQ38065264-848A17A7-8607-4082-8C6A-12B1EB70AEF8Q38259322-9E67834B-2BAD-40C1-9D18-D34EA0FA3A4CQ38463397-18ABC0BE-021C-44C9-BD06-4AD6F7EC3A6EQ38780267-B331E3D6-57A6-456F-B78B-6C580079877AQ38834031-A4A966AD-0653-4B29-B42B-F2F0C6B9C9D5Q38887592-2DF6DA3A-82F5-4D10-8F7B-64FE19953FDDQ39335656-6EE19B39-8047-463D-A095-4623BE2DD504Q39411394-BD504898-2E0F-49B9-8A68-7DC66922009AQ42288454-60ABCB35-CA8A-43A4-9D8B-CD02E4749107Q55509913-A9B13B8B-16D2-47E3-AAF5-F5C11083F6FEQ59047334-3CCAE0A0-29A1-49E4-989C-D6565EC12734
P2860
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@ast
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@en
type
label
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@ast
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@en
prefLabel
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@ast
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@en
P2093
P2860
P356
P1433
P1476
YB-1 evokes susceptibility to ...... unction and HER2 amplification
@en
P2093
A H Davies
A L Stratford
I M Berquin
M R Pambid
P2860
P2888
P304
P356
10.1038/ONC.2011.82
P407
P577
2011-03-21T00:00:00Z
P5875
P6179
1002224856